Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 20 June 1975:
Vol. 188. no. 4194, pp. 1217 - 1219
DOI: 10.1126/science.1145194
Prev | Table of Contents | Next

Articles

Science, Vol 188, Issue 4194, 1217-1219
Copyright © 1975 by American Association for the Advancement of Science

articles

Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons

P Seeman and T Lee

Neuroleptic (antipsychotic) drugs inhibited the electrically stimulated release of [3-H] dopamine from rat striatal slices. The concentrations for 50 percent inhibition (ranging from 11.5 nanomolar for spiroperidol to 800 nanomolar for thioridazine) correlated closely with the average daily dosages of 25 neuroleptic drugs used clinically for schizophrenia. The correlation includes butyrophenones, phenothiazines, reserpine, pimozide, clozapine, and (plus)- butaclamol. Clinically inactive isomers [trans-thiothixene, trans-flupenthixol, and (minus)-butaclamol] required 20 to 1000 times higher concentrations than the active isomers to inhibit release. Compared to the inhibition of [3-H] dopamine release, much higher neuroleptic concentrations were needed to inhibit the electrically stimulated release of other neurotransmitters--[3-H] acetylcholine, [3-H-a1 (gamma-aminobutyric acid). The neuroleptic drugs may block the presynaptic coupling between impulse and neurosecretion.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Cortical Dopamine D2/D3 Receptors Are a Common Site of Action for Antipsychotic Drugs--An Original Patient Data Meta-analysis of the SPECT and PET In Vivo Receptor Imaging Literature.
J. M. Stone, J. M. Davis, S. Leucht, and L. S. Pilowsky (2009)
Schizophr Bull 35, 789-797
   Abstract »    Full Text »    PDF »
Presynaptic Regulation of Dopamine Transmission in Schizophrenia.
G. J. Lyon, A. Abi-Dargham, H. Moore, J. A. Lieberman, J. A. Javitch, and D. Sulzer (2009)
Schizophr Bull
   Abstract »    Full Text »    PDF »
The Effect of Antipsychotics on the High-Affinity State of D2 and D3 Receptors: A Positron Emission Tomography Study With [11C]-(+)-PHNO.
A. Graff-Guerrero, D. Mamo, C. M. Shammi, R. Mizrahi, H. Marcon, P. Barsoum, P. Rusjan, S. Houle, A. A. Wilson, and S. Kapur (2009)
Arch Gen Psychiatry 66, 606-615
   Abstract »    Full Text »    PDF »
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway.
O. D. Howes and S. Kapur (2009)
Schizophr Bull 35, 549-562
   Abstract »    Full Text »    PDF »
Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis.
O. D. HOWES, A. J. MONTGOMERY, M. ASSELIN, R. M. MURRAY, P. M. GRASBY, and P. K. McGUIRE (2007)
The British Journal of Psychiatry 191, s13-s18
   Abstract »    Full Text »    PDF »
Ether-a-go-go Related Gene Potassium Channels: What's All the Buzz About?.
P. D. Shepard, C. C. Canavier, and E. S. Levitan (2007)
Schizophr Bull 33, 1263-1269
   Abstract »    Full Text »    PDF »
Involvement of 5-HT1A Receptors in Prefrontal Cortex in the Modulation of Dopaminergic Activity: Role in Atypical Antipsychotic Action.
L. Diaz-Mataix, M. C. Scorza, A. Bortolozzi, M. Toth, P. Celada, and F. Artigas (2005)
J. Neurosci. 25, 10831-10843
   Abstract »    Full Text »    PDF »
Partial agonism and schizophrenia.
A. A. Bolonna and R. W. Kerwin (2005)
The British Journal of Psychiatry 186, 7-10
   Full Text »    PDF »
D2 receptor regulation of synaptic burst firing in prefrontal cortical pyramidal neurons.
Y. Wang and P. S. Goldman-Rakic (2004)
PNAS 101, 5093-5098
   Abstract »    Full Text »    PDF »
Delayed-Onset Hypothesis of Antipsychotic Action: A Hypothesis Tested and Rejected.
O. Agid, S. Kapur, T. Arenovich, and R. B. Zipursky (2003)
Arch Gen Psychiatry 60, 1228-1235
   Abstract »    Full Text »    PDF »
Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia.
A. Abi-Dargham and H. Moore (2003)
Neuroscientist 9, 404-416
   Abstract »    PDF »
Inverse Agonist Actions of Typical and Atypical Antipsychotic Drugs at the Human 5-Hydroxytryptamine2C Receptor.
L. Rauser, J. E. Savage, H. Y. Meltzer, and B. L. Roth (2001)
J. Pharmacol. Exp. Ther. 299, 83-89
   Abstract »    Full Text »    PDF »
Neurochemical Individuality: Genetic Diversity Among Human Dopamine and Serotonin Receptors and Transporters.
A. Cravchik and D. Goldman (2000)
Arch Gen Psychiatry 57, 1105-1114
   Abstract »    Full Text »    PDF »
Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies.
M. Laruelle and A. Abi-Dargham (1999)
J Psychopharmacol 13, 358-371
   Abstract »    PDF »
Selective Action of Acute Systemic Clozapine on Acetylcholine Release in the Rat Prefrontal Cortex by Reference to the Nucleus Accumbens and Striatum.
M. A. Parada, L. Hernandez, M. P. De Parada, P. Rada, and E. Murzi (1997)
J. Pharmacol. Exp. Ther. 281, 582-588
   Abstract »    Full Text »
Analysis of the D4 Dopamine Receptor Gene Variant in an Italian Schizophrenia Kindred.
F. Macciardi, A. Petronis, H. H. M. Van Tol, C. Marino, M. C. Cavallini, E. Smeraldi, and J. L. Kennedy (1994)
Arch Gen Psychiatry 51, 288-293
   Abstract »    PDF »
Burst firing in dopamine neurons induced by N-methyl-D-aspartate: role of electrogenic sodium pump.
S. Johnson, V Seutin, and R. North (1992)
Science 258, 665-667
   Abstract »    PDF »
Early psychopharmacology and the rise of modern brain research.
A. Carlsson (1990)
J Psychopharmacol 4, 120-126
   PDF »
Controlled Study of Haloperidol, Pimozide, and Placebo for the Treatment of Gilles de la Tourette's Syndrome.
E. Shapiro, A. K. Shapiro, G. Fulop, M. Hubbard, J. Mandeli, J. Nordlie, and R. A. Phillips (1989)
Arch Gen Psychiatry 46, 722-730
   Abstract »    PDF »
Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients.
D Pickar, R Labarca, M Linnoila, A Roy, D Hommer, D Everett, and S. Paul (1984)
Science 225, 954-957
   Abstract »    PDF »
Pavlovian conditional tolerance to haloperidol catalepsy: evidence of dynamic adaptation in the dopaminergic system.
C. Poulos and R Hinson (1982)
Science 218, 491-492
   Abstract »    PDF »
Schizophrenia: dopamine beta-hydroxylase activity and treatment response.
D. Sternberg, D. VanKammen, P Lerner, and W. Bunney (1982)
Science 216, 1423-1425
   Abstract »    PDF »
Antipsychotic Effects of Pimozide in Schizophrenia: Treatment Response Prediction With Acute Dextroamphetamine Response.
D. P. van Kammen, J. P. Docherty, S. R. Marder, S. C. Schulz, L. Dalton, and W. E. Bunney Jr (1982)
Arch Gen Psychiatry 39, 261-266
   Abstract »    PDF »
Stimulated Lymphocytes in Schizophrenia.
M. Hirata-Hibi, S. Higashi, T. Tachibana, and N. Watanabe (1982)
Arch Gen Psychiatry 39, 82-87
   Abstract »    PDF »
Antipsychotic drug action in schizophrenic patients: effect on cortical dopamine metabolism after long-term treatment.
N. Bacopoulos, E. Spokes, E. Bird, and R. Roth (1979)
Science 205, 1405-1407
   Abstract »    PDF »
Thiethylperazine: Clinical Antipsychotic Efficacy and Correlation With Potency in Predictive Systems.
J. Rotrosen, B. M. Angrist, S. Gershon, M. Aronson, P. Gruen, E. J. Sachar, R. K. Denning, S. Matthysse, M. Stanley, and S. Wilk (1978)
Arch Gen Psychiatry 35, 1112-1118
   Abstract »    PDF »
Neuroleptic-induced "anhedonia" in rats: pimozide blocks reward quality of food.
R. Wise, J Spindler, H deWit, and G. Gerberg (1978)
Science 201, 262-264
   Abstract »    PDF »
Prolactin Responses to Neuroleptics in Normal and Schizophrenic Subjects.
P. H. Gruen, E. J. Sachar, G. Langer, N. Altman, M. Leifer, A. Frantz, and F. S. Halpern (1978)
Arch Gen Psychiatry 35, 108-116
   Abstract »    PDF »
An adenylate cyclase of brain reflects propensity for breast cancer in mice.
G. Cotzias and L. Tang (1977)
Science 197, 1094-1096
   Abstract »    PDF »
Catatonic Reactions to High-Potency Neuroleptic Drugs.
A. J. Gelenberg and M. R. Mandel (1977)
Arch Gen Psychiatry 34, 947-950
   Abstract »    PDF »
Dopamine Receptors and Average Clinical Doses.
I. CREESE, D. R. BURT, and S. H. SNYDER (1976)
Science 194, 546
   PDF »
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.
I Creese, D. Burt, and S. Snyder (1976)
Science 192, 481-483
   Abstract »    PDF »
The Effect of Neuroleptics on Serum Prolactin in Schizophrenic Patients.
H. Y. Meltzer and V. S. Fang (1976)
Arch Gen Psychiatry 33, 279-286
   Abstract »    PDF »
Self-inhibition by dopaminergic neurons.
P. Groves, C. Wilson, S. Young, and G. Rebec (1975)
Science 190, 522-528
   PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)